Study to Investigate the Safety, Tolerability and Pharmacokinetics of AD 452 [(+)-Mefloquine] Compared With Racemic Mefloquine
Phase 1
Completed
- Conditions
- Healthy Subjects
- Interventions
- First Posted Date
- 2009-07-02
- Last Posted Date
- 2010-08-03
- Lead Sponsor
- Treague Ltd
- Target Recruit Count
- 46
- Registration Number
- NCT00931697
- Locations
- 🇬🇧
LCG Bioscience, Cambridge, Cambridgeshire, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath